Progress toward curing HIV infection with hematopoietic cell transplantation.
Abstract
HIV-1 infection afflicts more than 35 million people worldwide, according to 2014
estimates from the World Health Organization. For those individuals who have access
to antiretroviral therapy, these drugs can effectively suppress, but not cure, HIV-1
infection. Indeed, the only documented case for an HIV/AIDS cure was a patient with
HIV-1 and acute myeloid leukemia who received allogeneic hematopoietic cell transplantation
(HCT) from a graft that carried the HIV-resistant CCR5-∆32/∆32 mutation. Other attempts
to establish a cure for HIV/AIDS using HCT in patients with HIV-1 and malignancy have
yielded mixed results, as encouraging evidence for virus eradication in a few cases
has been offset by poor clinical outcomes due to the underlying cancer or other complications.
Such clinical strategies have relied on HIV-resistant hematopoietic stem and progenitor
cells that harbor the natural CCR5-∆32/∆32 mutation or that have been genetically
modified for HIV-resistance. Nevertheless, HCT with HIV-resistant cord blood remains
a promising option, particularly with inventories of CCR5-∆32/∆32 units or with genetically
modified, human leukocyte antigen-matched cord blood.
Type
Journal articleSubject
CCR5 mutationCCR5-∆32/∆32 cord blood inventory
curing HIV infection
genetic modification of stem cells
hematopoietic cell transplantation
Permalink
https://hdl.handle.net/10161/24631Published Version (Please cite this version)
10.2147/sccaa.s56050Publication Info
Petz, Lawrence D; Burnett, John C; Li, Haitang; Li, Shirley; Tonai, Richard; Bakalinskaya,
Milena; ... Rossi, John J (2015). Progress toward curing HIV infection with hematopoietic cell transplantation. Stem cells and cloning : advances and applications, 8. pp. 109-116. 10.2147/sccaa.s56050. Retrieved from https://hdl.handle.net/10161/24631.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Joanne Kurtzberg
Jerome S. Harris Distinguished Professor of Pediatrics
Dr. Kurtzberg is an internationally renowned expert in pediatric hematology/oncology,
pediatric blood and marrow transplantation, umbilical cord blood banking and transplantation,
and novel applications of cord blood and birthing tissues in the emerging fields of
cellular therapies and regenerative medicine. Dr. Kurtzberg serves as the Director
of the Marcus Center for Cellular Cures (MC3), Director of the Pediatric Transplant
and Cellular Therapy Program, Director of the Carolina

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info